Eli Lilly Must Pay $61M For False Medicaid Rebate Calculation
An Illinois federal jury hit Eli Lilly and Co. with a $61 million verdict Wednesday after finding that the drug manufacturer deliberately shorted the Medicaid program by leaving retroactive drug price...To view the full article, register now.
Already a subscriber? Click here to view full article